2-Chloropyrimidine → HCID 21298810, compound

HRID 1902317Notes

Reaction equation

HRID 1902317 reaction equation
[F:1][C:2]([F:19])([F:18])[CH2:3][N:4]=[C:5]([NH2:17])[NH:6][C:7]1[S:8][CH:9]=[C:10]([CH2:12][CH2:13][CH2:14][CH2:15][NH2:16])[N:11]=1.Cl[C:21]1[N:26]=[CH:25][CH:24]=[CH:23][N:22]=1>C(#N)C>[F:19][C:2]([F:1])([F:18])[CH2:3][N:4]=[C:5]([NH2:17])[NH:6][C:7]1[S:8][CH:9]=[C:10]([CH2:12][CH2:13][CH2:14][CH2:15][NH:16][C:21]2[N:26]=[CH:25][CH:24]=[CH:23][N:22]=2)[N:11]=1

Participants

4

Procedure

A mixture of 2-[2-(2,2,2-trifluoroethyl)-guanidino]-4-(4-aminobutyl)thiazole (0.45 g.) and 2-chloropyrimidine (0.18 g.) was heated under reflux in acetonitrile (5 ml.) for 16 hours. The reaction mixture was then evaporated to dryness and the residue purified by medium pressure liquid chromatography on silica gel using chloroform/methanol/ammonia 1900:100:5 v/v/v as eluant. The appropriate fraction was evaporated to dryness and the residue recrystallised from acetonitrile to give 2-(4-[2-(2-[2,2,2-trifluoroethyl]guanidino)-thiazol-4-yl]butylamino)pyrimidine (0.29 g.), m.p. 173°-175°.

Workup

  1. temperaturewas heated
  2. customThe reaction mixture was then evaporated to dryness
  3. customthe residue purified by medium pressure liquid chromatography on silica gel
  4. customThe appropriate fraction was evaporated to dryness
  5. customthe residue recrystallised from acetonitrile

Sources & evidence

ORD record
ord-92cc3cc179524c268b8c2e0895fd8f53
Source dataset
uspto-grants-1982_12
Patent number
US04362728

Reaction notes

Loading…